In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a ICG Drug Master File in Korea (ICG KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of ICG. The MFDS reviews the ICG KDMF as part of the drug registration process and uses the information provided in the ICG KDMF to evaluate the safety and efficacy of the drug.
After submitting a ICG KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their ICG API can apply through the Korea Drug Master File (KDMF).
click here to find a list of ICG suppliers with KDMF on PharmaCompass.